Diabetes Meet 2019

Theme: Novel Innovations and Advances in Diabetes Management

Diabetes Meet 2019

Scientific Program 2019

Renowned Speakers

Premanidhi Panda
Dr. Panda Diabetes Centre
India

Joseph F. Ndisang
University of Saskatchewan College of Medicine

Canada

Khalid Khalaf Alharbi
King Saud University
Saudi Arabia

Goutam Kumar Acherjya
Upazila Health Complex
Bangladesh

M. S. Umashankar
SRM University
India

Saneh Khunkaew
University of Wollongong School of Nursing
Australia

Zogopoulos Panagiotis
Metropolitan Hospital
Greece

Gerald C. Hsu
eclaireMD Foundation
USA

Ian James Martins
Edith Cowan Unversity
Australia

Conference Series Llc Ltd is happy to announce the "2nd Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome" scheduled through May 17-18, 2018 in Singapore with a theme, “Novel Innovations and Management in Diabetes Management”.

Conference Series Llc Ltd organizes a thousand International Conferences each year across USA, Europe & Asia with support from a lot of scientific societies and publishes 500+ Open access journals that contain over 50000 eminent personalities, 50,000 acknowledged scientists as editorial board members and five million readers.

Diabetes is a chronic disease that happens either once the exocrine gland doesn't produce enough insulin or once the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood glucose. The metabolic syndrome is a cluster of the most dangerous coronary failure risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high pressure level. In 2014, 8.5% of adults aged eighteen years and older had diabetes. In 2015, diabetes was the direct reason behind 1.6 million deaths and in 2012 high blood sugar was the reason behind another 2.2 million deaths.

Hypertension also called high pressure is a long-term medical condition during which the pressure within the arteries is persistently elevated. Hypertension could be a condition that’s typically present in individuals with type two diabetes. It’s unknown why there’s such a significant correlation between the 2 diseases. It’s believed that obesity, a diet high in fat and sodium, and inactivity contribute to each condition.

Scope and Importance:-

Diabetes is one among the rising diseases that is turning into quite common these days. Diabetes is a metabolic disease during which the individual has high blood glucose (sugar), either as a result of insulin production is insufficient, or as a result of the body's cells don't respond properly to insulin or both. Patients with high blood glucose can experience polyuria (frequent urination), polydipsia (excessive thirst) and polyphagia (frequent hunger). With the modification in lifestyle, our endocrine system of the body is getting disturbed. Health care is very important as diseases like diabetes, that is a metabolic syndrome is getting increases day by day. In order to induce innovative, the meeting will concentrate on the most recent and exciting innovations in all areas of endocrinology research providing a unique chance for international explorers to assemble, network, and grasp new scientific innovations. The studies are a lot of connected with the topics like Current Advances in Endocrinology & Metabolism; Chemistry, Physiology, and Disorders associated with Hypothalamus-Pituitary Axis, Thyroid and Parathyroid glands and its Disorders, Reproductive Endocrinology, Diabetic Disorders and Treatment, Energy Balance and Obesity, Treatment and Identification of Endocrine Diseases, Surgery, Mechanism of action of Peptide Hormones and Receptors and Steroid Hormones and Receptors, Glycoprotein Hormones (LSH, FSH, TH, hCG, POMC), Somatotropin family (GH, hCS, Prolactin), Adrenal Hormones and Endocrine regulation. The speech involves the main area to be covered so that at a brief time, we are able to discuss and realize the means and create a brand new discovery within the field of Diabetes and Endocrinology.

Why attend???

Medical doctors, patients and health care providers take into account the prevention of diabetes & metabolic syndrome as a vital tool to enhance the overall health status of the population. The proportions of individuals affected by the diabetes, high blood pressure & Metabolic Syndrome are expected to extend in future according to a recent statistical survey. Realizing this imperative, Conference Series Ltd is ready to organize "Global experts Meeting on diabetes, hypertension, Metabolic Syndrome" for the coming year with a view to boost research and promote awareness aiming in developing solutions for the challenges encountered.

Target Audience:

Medical College Faculty and Students
Endocrinology & Diabetes Researchers and Scholars
Endocrinology & Diabetes Professors
Endocrinology & Diabetes Associations and Societies
Diabetes Institutes
Hypertension & Cardiology Researchers and Professors
Hypertension Associations and Societies
Hypertension Institutes
Research Students
Business Entrepreneurs
Pharmaceutical Companies
Medical Devices Manufacturing Companies

Track 1: Diabetes Type and Symptoms

Diabetes Mellitus, simply cited as diabetes, is a cluster of metabolic diseases resulting in prolonged high blood sugar. Diabetes is caused either due to inadequate insulin production, mentioned as type one diabetes or because of resistance to insulin by body’s cells, mentioned as type two diabetes or sometimes both of them along. Symptoms of diabetes include polyuria along with an increase in thirst and hunger.

Type 1 Diabetes
Type 2 Diabetes
Pre-Diabetes
Borderline Diabetes
Polyuria

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Austrian Diabetes Association | Flemish Diabetes Association | Croatian Diabetes Association | Union of Diabetics of Czech Republic | Estonian Diabetes Association

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 2: Gestational Diabetes

During gestation, about 4% of women develop a diabetes-like condition that affects how body cells react to glucose. It’s primarily because of hormonal secretion and fat deposition throughout pregnancy that develops insulin resistance. In most of the cases blood sugar level returns to normal after gestation, however, there's a risk for type two diabetes.

Prognosis of Gestational Diabetes
Risk Factors for Gestational Diabetes and Hypertension
Monitoring Fetal Growth and Well-being
Difficulties during Delivery due to Gestational Diabetes
Treatment of Gestational Diabetes

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Finnish Diabetes Association | French Diabetics Association | German Diabetes Union | Hellenic Diabetes Association | Icelandic Diabetic Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 3: Neonatal and Juvenile Diabetes

Neonatal diabetes mellitus is a kind of diabetes that is regulated by one single gene (monogenic) in infants during the first six months. Infants accumulate a great deal of glucose thanks to the inability to provide enough insulin. It’s most typically mistaken as type one or juvenile diabetes that happens after six months of age primarily in children. In juvenile diabetes, the pancreas produces very little to no internal secretion. It had been termed juvenile diabetes because it typically appears in children and adolescents, however, can develop in adults too.

Permanent Neonatal Diabetes Mellitus
Transient Neonatal Diabetes Mellitus
Symptoms of Diabetes in Children
Unexplained Weight Loss
Glycosuria in Diabetic Child

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Diabetes Federation of Ireland | Netherlands Diabetes Association | Norwegian Diabetes Association | Polish Diabetes Association | Diabetic Association of Portugal

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 4: Diabetic Complications

If left untreated, diabetes develops several health complications like Diabetic Ketoacidosis and Nonketotic Hyperosmolar Coma among others. Acute complications additionally include hyperglycemia and even diabetic coma. The foremost common serious diabetic complications are coronary artery disease (CAD) and stroke, renal failure, blindness, and diabetic foot disease.

Diabetic Angiopathy
Diabetic Ketoacidosis
Diabetic Osteopathy
Diabetes and Obesity
Diabetes and Dermatological Problems
Diabetic Foot and Ankle

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Spanish Diabetes Society | Diabetes UK | Swedish Diabetes Association | Swiss Diabetes Society | Luxembourg Diabetes Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 5: Diabetic Retinopathy

Diabetic Retinopathy or Diabetic Eye Disease is a cluster of ophthalmic issues in diabetic individuals because of prolonged hyperglycaemia. In Diabetic Retinopathy, blood vessels within the eye swell and leak. In some individuals, abnormal growth of blood vessels over retina is additionally observed. Over time, it's going to cause permanent loss of vision in each of the eyes. In the United States alone Diabetic Retinopathy claims 12% of all new cases of blindness.

Signs and Symptoms
Risk Factors
Diagnosis & Pathogenesis
Laser Photocoagulation
Proliferative Diabetic Retinopathy
Research

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Austrian Diabetes Association | Flemish Diabetes Association | Croatian Diabetes Association | Union of Diabetics of Czech Republic | Estonian Diabetes Association

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 6: Diabetic Nephropathy

Diabetic Nephropathy or Diabetic Kidney Disease is a complication wherever blood vessels within the kidney are broken which can even result in nephrosis in some cases. Because of improper function of the kidney, the body retains additional water and salt that results in weight gain and swelling of joints especially ankle

Albuminuria
Symptoms and Diagnosis of Diabetic Kidney Disease
Treatment and Prevention of Diabetic Nephropathy

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Finnish Diabetes Association | French Diabetics Association | German Diabetes Union | Hellenic Diabetes Association | Icelandic Diabetic Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 7: Genetic Basis of Diabetes

Along with nutrition and exercise, genetics play a serious role for an individual to develop type two diabetes. The heritability of diabetes and metabolic syndrome is comparatively high and several other gene mutations are coupled to the event of type two diabetes. About 70% of type two diabetes patient inherited the disease from the previous generation.

Diagnosis and Management Resources
Reducing the Risk of Passing Diabetes
Identifying the Genes Responsible for Type 2 Diabetes
The Role of Genetics in Type 2 Diabetes
Genetic Testing for Type 2 Diabetes and Prevention Tips
Lifestyle Choices that Affect the Development of Type 2 Diabetes

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Diabetes Federation of Ireland | Netherlands Diabetes Association | Norwegian Diabetes Association | Polish Diabetes Association | Diabetic Association of Portugal

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 8: Biomarkers of Diabetes

Biomarkers are molecular markers used as direct or indirect markers of the extent of an illness. HbA1c is taken into account as the biomarker in diabetes for assessing the risk factor associated with retinopathy, renal disorder and other vascular diseases. Biomarkers alter preventive measures to be applied at the subclinical stage and also the responses to preventive or therapeutic measures to be monitored.

Novel Biomarkers
Advances in Molecular Diagnostics
HbA1c Biomarker

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Spanish Diabetes Society | Diabetes UK | Swedish Diabetes Association | Swiss Diabetes Society | Luxembourg Diabetes Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 9: Diagnostic Approach

Diabetes may be diagnosed by analysis of blood sample based on plasma and glucose criteria or A1C criteria. Glucose calculating finger stick devices may be used as a fast indicator however they are not precise. To confirm that test results are correct laboratory study of blood is needed.

Glycated Hemoglobin (A1C) Test
Exercise Test
Fasting Test
Glucagon Test
Glucose Tolerance Test

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Austrian Diabetes Association | Flemish Diabetes Association | Croatian Diabetes Association | Union of Diabetics of Czech Republic | Estonian Diabetes Association

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 10: Diabetes Management and Education

Diabetes can often be managed through correct diet, nutrition and exercise. Diabetic nursing conjointly plays a vital role in the management of diabetes. Patients diagnosed with diabetes have a higher risk of some kind of cancer. Therefore proper management and education regarding diabetic care are required.

Ketogenic Diet for Diabetes
Medical Nutrition Therapy
Diabetes Foot Care and Management
Cardiac Resynchronization Therapy
Implantable Cardioverter Defibrillator

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Finnish Diabetes Association | French Diabetics Association | German Diabetes Union | Hellenic Diabetes Association | Icelandic Diabetic Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 11: Anti-Diabetic Medication

Anti-Diabetic Medications work by either lowering down glucose level or by increasing sensitivity to insulin. Type one diabetes is caused by lack of insulin therefore, insulin must be administered subcutaneously. Type two diabetes is treated by oral hypoglycemic agents that act either by (a) increasing the quantity of insulin secreted by the pancreas, (b) increasing the sensitivity of target organs to insulin or (c) decreasing the rate at which glucose is absorbed from the GI tract.

Human Recombinant Insulin
Biguanides
Sulphonylureas
Meglitinides
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Incretin Agonists

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Diabetes Federation of Ireland | Netherlands Diabetes Association | Norwegian Diabetes Association | Polish Diabetes Association | Diabetic Association of Portugal

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 12: Medical Devices and Technologies used in Diabetes Treatment

The most common medical devices utilized in diabetes include blood-glucose meters, insulin pumps and insulin pens. An artificial pancreas is a machine which would monitor blood sugar levels using an array of sensors, and unleash insulin from a reservoir into the blood, using an infusion pump, whenever it's needed. Current gene therapy study highlights the transfer of insulin gene into different cells like the liver, stomach, or intestines.

Drug Therapy and Insulin Pumps
Bioartificial Pancreas
Bariatric Surgery
Gene Therapy and Cell-Replacement Therapy
Monoclonal Antibodies
Bioinformatics in Diabetes Mellitus
Telemedicine and Computational Application

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Spanish Diabetes Society | Diabetes UK | Swedish Diabetes Association | Swiss Diabetes Society | Luxembourg Diabetes Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 13: Stem Cell Therapy and Nanotechnology in Diabetes

A successful bone marrow or stem cell transplant could facilitate slow or halt the progression of certain metabolic syndromes together with type one diabetes, however, early diagnosis is vital to prevent irreversible disease progression. Pancreatic islet allotransplantation is a procedure in which islets from the donor pancreas are transferred into another person to treat type one diabetes and have been a promising cellular-based therapy. The recent advances in nanomedicine include smart medication that solely activates when needed, nanoformulations for efficient drug delivery, engineered microbes that manufacture human hormones, and even nanorobots, which would move autonomously around the body acting as a boost, for our immune system, red blood cells, or several other biological systems.

Islet Cell Transplantation
Embryonic Stem Cells
Mesenchymal Stem Cell Therapy

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Austrian Diabetes Association | Flemish Diabetes Association | Croatian Diabetes Association | Union of Diabetics of Czech Republic | Estonian Diabetes Association

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 14: Alternative and Herbal Medicine in Diabetes

Herbal Medicines also referred to as phytomedicines, are utilised for health and restorative functions for an extended period of time. Plant sources like aloe vera, cardamom, bilberry extract, bitter melon, fenugreek, ginger, okra, garlic, genus Bauhinia forficata, ivy gourd, ginseng have shown anti-diabetic properties. Several herbal supplements are sold as tablets, capsules, powders, teas, extracts, and fresh or dry plants.

Herbal Drugs Used for the Treatment of Diabetes
Natural Remedies Used in Diabetes Care
Improvement of Glucose Tolerance by Herbal Drugs
Herbal and Natural Supplements for Diabetes
Importance and Usage of Herbal Medicine
Other Alternative Remedies

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Finnish Diabetes Association | French Diabetics Association | German Diabetes Union | Hellenic Diabetes Association | Icelandic Diabetic Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 15: Diabetes and Metabolic Syndrome

A cluster of conditions like enhanced blood pressure, high blood glucose, excess body fat, abnormal triglyceride and cholesterol levels result in metabolic syndrome. People having diabetes during pregnancy (gestational diabetes) or a case history of type two diabetes are a lot likely to develop metabolic syndrome. Aggressive lifestyle changes will delay or prevent serious complications. If left uncontrolled, it will increase the chance of insulin resistance, diabetes, cardiovascular diseases like high blood pressure and even stroke.

Symptoms of Metabolic Syndrome
Causes and Risk Factors of Metabolic Syndrome
Complications in Metabolic Syndrome

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Diabetes Federation of Ireland | Netherlands Diabetes Association | Norwegian Diabetes Association | Polish Diabetes Association | Diabetic Association of Portugal

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 16: Diabetes Induced Heart Complications

Diabetes intensifies the danger of long-run complications. Diabetes will increase the danger of cardiovascular diseases like Diabetic Myocardiopathy. The chief complications of diabetes because of injury in tiny blood vessels comprise damage to the eyes, kidneys, and nerves. It’s going to additionally result in arteriosclerosis caused by high pressure, lack of exercise, obesity, high blood cholesterol, poor diet and excessive alcohol consumption among others.

High Blood Pressure
High Cholesterol Level
Coronary Artery Disease
Atherosclerosis
Stroke
Heart Attack

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Spanish Diabetes Society | Diabetes UK | Swedish Diabetes Association | Swiss Diabetes Society | Luxembourg Diabetes Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 17: Hypertension

Hypertension is a rise of the pressure level within the artery, vein or capillaries, leading to shortness of breath, dizziness, fainting, swelling of legs and different other symptoms. Hypertension is caused once blood vessels become narrowed, blocked or destroyed making it tougher for the blood to flow through them. Because the pressure builds, the heart's lower right chamber should work harder to pump blood through the lungs, eventually causing the cardiac muscles to weaken and eventually fail. Hypertension worsens over time and is grave because the pressure in a patient's pulmonary arteries rises to hazardously high levels, putting a strain on the heart. The various complications associated with hypertension are congestive heart failure, clotting, liver disease, Lupus, rheumatism, bronchitis, HIV Associated pulmonary hypertension, and pulmonary hypertension in Association with sickle cell anaemia.

Pulmonary Hypertension
Gestational Hypertension
The relation between Hypertension and Diabetes
The relation between Hypertension and Stroke
Hypertensive Heart Disease

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Austrian Diabetes Association | Flemish Diabetes Association | Croatian Diabetes Association | Union of Diabetics of Czech Republic | Estonian Diabetes Association

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 18: Pathophysiology and Diagnosis of Hypertension

Hypertension, or high pressure, is the leading risk issue related to death in the world, however, is basically symptomless and often undetected in patients. Once hypertension has been diagnosed, additional tests ought to be conducted, together with urine testing, blood tests, an eye examination and a 12-lead electrocardiogram (ECG). Primary hypertension, in which no specific cause is found, affects 95% of patients. Hypertension is diagnosed once either systolic pressure, diastolic pressure, or both are raised. Blood pressure is calculated by the cardiac output balanced against systemic vascular resistance. The method of maintaining blood pressure is complicated, and involves various physiological mechanisms, together with arterial baroreceptors, the renin–angiotensin–aldosterone system, atrial natriuretic peptide, endothelins, and mineralocorticoid and glucocorticoid steroids.

Renin–Angiotensin–Aldosterone System
Endothelial Dysfunction
Vascular Damage in Hypertension
Sodium /Potassium Ratio Hypothesis of Essential Hypertension
Endoscopy
Echocardiogram
Polysomnogram

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Finnish Diabetes Association | French Diabetics Association | German Diabetes Union | Hellenic Diabetes Association | Icelandic Diabetic Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Track 19: Cholesterol, High Blood Pressure and Diabetes

Cholesterol is employed by the body in the production of vitamin D, bound hormones and building healthy cells. High cholesterol level and diabetes are connected to each other as diabetes will disturb the balance between HDL cholesterol and LDL cholesterol levels. LDL particles in diabetic people tend to stick to arteries and may easily harm blood vessel walls. Glucose coated low-density lipoprotein remains within the blood longer and will result in the formation of plaque. Low high-density lipoprotein levels are seen within the people with diabetes. Each of these increases the chance of heart and artery malady. There is also a direct link between high blood pressure and high cholesterol. Once the arteries become narrowed and hardened with cholesterol plaque, the heart needs to force a lot harder to pump blood through them. As a result, blood pressure becomes suddenly high.

High-Density Lipoproteins and Low-Density Lipoproteins
Dietary Sources of Cholesterol
Impaired Blood Vessels
Circulatory Problems
Increase in the Amount of Body Fluids
Changes in Insulin Management
Lifestyle Changes to Lower Cholesterol

Related Societies:

Asia-Pacific: Diabetic Society of Singapore | Diabetes Australia | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association

Europe: Diabetes Federation of Ireland | Netherlands Diabetes Association | Norwegian Diabetes Association | Polish Diabetes Association | Diabetic Association of Portugal

North and South America: Canadian Diabetes Association | American Diabetes Association | Juvenile Diabetes Foundation of Chile | Diabetological Colombian Federation | Mexican Diabetes Federation

Track 20: Emerging Focus in Diabetes Research

In spite of scientific innovations and better healthcare amenities, diabetes continues to burden varied segments, notably middle and low-income countries. The current trends designate the rise in premature mortality, imposing a significant threat to world development. The advancement in science and technology has discovered the growth of the newer generation of nanomedicine in drug discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have reworked the investigation of drug discovery and lead identification for diabetes management.

Bio-Stator: Closed Loop System
New Insulin Conveyance Systems: Inhaled, Transdermal and Embedded Devices
Computational Approach to Chemical Etiologies of Diabetes
New Therapeutic Mechanisms for Diabetes
Advanced Nutrition and Dietetics in Diabetes

Related Societies:

Asia-Pacific: Hong Kong Diabetes Federation | Diabetes New Zealand | Diabetes Association of the Republic of China | Diabetes Philippines | Australian Diabetes Society

Europe: Spanish Diabetes Society | Diabetes UK | Swedish Diabetes Association | Swiss Diabetes Society | Luxembourg Diabetes Association

North and South America: American Association of Clinical Endocrinologists | Sociedade Brasileira de Diabetes | Sociedad Argentina de Diabetes | Diabetes Association of Jamaica | Diabetes Canada

Market Growth:

With the appalling increase in the prevalence of varied hormone-related medical conditions, like hypogonadism, diabetes, hyperthyroidism, and hypothyroidism, the world market for endocrinology medicine market has been witnessing a motivating upsurge in its overall size and valuation. Since the incidence rate of diabetes is exceptionally high across the globe, fueled by an unhealthy diet and also the reducing involvement of customers in physical activities, the world market is likely to maintain a high-paced rise in the coming years. The endocrinology medication market in the Americas is anticipated to achieve USD 41 billion by 2020, growing at a CAGR of over 6%.

The endocrinology medication market in EMEA can exceed USD 16 billion by 2020, growing at a CAGR of over 6%. The medicine medication market in APAC is anticipated to exceed USD 14 billion by 2020, growing at a CAGR of over 7% key suppliers being Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca, and AbbVie.

Due to the high prevalence of diabetes, the demand for diabetes medicine is beyond other products. Researchers expect this trend to stay thus over consecutive few years, leading to the high rate of growth of the diabetes drug segment. The introduction of novel drug therapies and also the presence of strong product pipelines during this market for the treatment of both varieties of diabetes are possible to add considerably to the increase of this segment in the years to come.

Societies Associated with Diabetes Care:

Endocrine Society Australia
Australia Diabetes Society
European Society of Endocrinology
Egyptian Association of Endocrinology, Diabetes, And Atherosclerosis
The American Association of Clinical Endocrinology
American Diabetes Association
Association of British Clinical Diabetologist
British Association of Endocrine and Thyroid Surgeons
British Society for Neuroendocrinology
British Society for Paediatric Endocrinology and Diabetes
International Neuroendocrine Federation
International Society of Endocrinology
International Society of Psychoneuroendocrinology
Panhellenic Association of Endocrinologists
Royal Society of Medicine Endocrinology and Diabetes Section
Spanish Society of Endocrinology and Nutrition.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 17-18, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

"This was an illuminating conference on Targeting Diabetes and Novel Therapeutics. The conference gave me great insight into this area: moreover, I enjoyed giving my own presentation to the professionals in this field which were present at this conference."
John Philip Tarburton, National University,
USA

"I enjoyed the conference, it was a wonderful experience, in all professional aspects. I became aware of new findings and trends in my research area, discussed them with the finest scientists all over the world, everything in a gorgeous place with superb facilities. It was indeed a remarkable experience."
Massimo Collino
University of Turin
Italy

"I am very grateful for the meaningful exchange of information about diseases and autoimmunity at the European Diabetes Congress."
Hidekatsu Yanai

"It was a great experience for me to participate and share my research in the European Diabetes Congress. Everything was well organized. The conference gave me great insight into the area of New Therapeutic Mechanism of Diabetes."
Qiang Tu, Flinders Unversity, Australia

"It was my pleasure participating in the European Diabetes Congress as an Honorable Guest, Keynote Speaker as well as OCM, in addition, to evaluate the poster session in the absence of originally appointed focal person, on this regard I would thank you all for inviting me and giving me this opportunity and meeting experts and exchanging experiences on diabetes from around the world. I hope that the next meeting will involve more distinguished researchers and experts on Diabetes and I will be happy to participate in the preparation and deliver the new research that I am working on now on diabetes education for the community"
Yousef Shahin, Chief UNRWA Jordan

"Thank you very much. I really enjoyed Euro Diabetes in Valencia. Hope to go to Germany as well."
Jazlina, Malaysia

2^ndGlobal Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome May 17-18, 2019 | Holiday Inn Atrium Singapore | Singapore

Recommended Global Diabetes & Endocrinology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Singapore Conference 2019

Singapore Conference 2019

Renowned Speakers